A Screening Study Assessing Eligibility of Idiopathic Parkinsons Disease Patients for Potential Future Intraputamenal Transplant Study with a Dopaminergic Precursor Product

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Paul Larson
Sponsor
Kenai Therapeutics Inc
Unit
Neurosurgery